Ag-Ticagrelor 90 mg (Ticagrelor TABLET) 90 MG

AG-Ticagrelor 90 mg tablets are an oral medication used to prevent blood clots. This antiplatelet drug helps manage cardiovascular conditions by reducing the risk of heart attacks and strokes.

Strength

90 MG

Manufacturer / TM Owner

ANGITA PHARMA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

AG-Ticagrelor 90 mg tablets are primarily used to prevent blood clots in individuals with cardiovascular conditions. This medication is often prescribed for patients who have experienced a heart attack or stroke, or for those at high risk of these events. It works by inhibiting platelet aggregation, which helps to maintain blood flow and reduce the risk of serious cardiovascular complications.

Side Effects

Common effects of AG-Ticagrelor 90 mg tablets may include bleeding, bruising, and dizziness. Some users might experience shortness of breath, nausea, or fatigue. These effects vary among individuals and are not exhaustive. Consult a healthcare provider for personalized advice.

Precautions & Warnings

AG-Ticagrelor 90 mg tablets should be handled with care. Inform your healthcare provider about any allergies or medical conditions before use. This medication may increase the risk of bleeding, so avoid activities that could cause injury. Store in a cool, dry place away from children.

Avoid Interactions

AG-Ticagrelor 90 mg tablets may interact with other medications, including blood thinners, NSAIDs, and certain antidepressants. Alcohol consumption should be limited, as it can increase the risk of bleeding. Always consult a healthcare provider before combining medications.

Frequently Asked Questions

AG-Ticagrelor 90 mg tablets are used to prevent blood clots in individuals with cardiovascular conditions, reducing the risk of heart attacks and strokes.

Store AG-Ticagrelor 90 mg tablets in a cool, dry place away from children and direct sunlight.

Common side effects may include bleeding, bruising, dizziness, shortness of breath, nausea, and fatigue.

AG-Ticagrelor 90 mg may interact with other medications, including blood thinners and NSAIDs. Consult a healthcare provider before combining medications.

AG-Ticagrelor 90 mg should be used with caution, especially in individuals with bleeding disorders or those taking other blood-thinning medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.